OSAKA, Japan–(BUSINESS WIRE)–Das Unternehmen Santen Pharmaceutical Co., Ltd. („Santen“), hat heute bekannt gegeben, dass es in Partnerschaft mit der International Agency for the Prevention of Blindness (IAPB) bei der Umsetzung der Resolution A/75/L.1…
Author: Business Wire
Santen et l'IAPB prennent des mesures pour mettre en œuvre la toute première résolution de l'Assemblée générale des Nations Unies reconnaissant le lien entre la santé oculaire et le développement durable
OSAKA, Japon–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (« Santen ») a annoncé aujourd’hui que Santen, en partenariat avec l’Agence internationale pour la prévention de la cécité (International Agency for the Prevention of Blindness, IAPB), pren…
Seventy-Five Percent of Color Blind People Experience Challenges at Work, EnChroma Study Finds
BERKELEY, Calif.–(BUSINESS WIRE)– #colorishere–75% of Color Blind People Experience Challenges at Work. EnChroma Study Finds Frustrations for Color Blind on the Job; Outlines Steps for Employers
Ocular Hypertension Epidemiology Forecast Report 2021-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Hypertension – Epidemiology Forecast to 2030” drug pipelines has been added to ResearchAndMarkets.com’s offering. This ‘Ocular Hypertension (OHT)-Epidemiology Forecast – 2030’ report delivers an in-depth understandi…
Global Contact Lens Markets Report 2021-2025 – Growing Smart Contact Lens Demand / Increased Consolidation of Market Players / Increasing Shift Towards Daily Lenses / Rising E-Commerce Sales – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lens Market: Insights & Forecast with Potential Impact of COVID-19 (2021-2025)” report has been added to ResearchAndMarkets.com’s offering. The global contact lens market is forecasted to reach US$11.02 …
Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule
NEW YORK–(BUSINESS WIRE)–Iveric Bio announced the early completion of patient enrollment of GATHER2, the Company’s 2nd pivotal clinical trial of Zimura® (avacincaptad pegol).
Riassunto: Santen e IAPB si impegnano a implementare la prima Risoluzione dell’assemblea generale delle Nazioni Unite che riconosce il collegamento tra salute oculare e sviluppo sostenibile
OSAKA, Giappone–(BUSINESS WIRE)–Santen Pharmaceutical Co., Ltd. (“Santen”) ha annunciato oggi che Santen, in collaborazione con l’Agenzia internazionale per la prevenzione della cecità (International Agency for the Prevention of Blindness, IAPB), si …
Santen and IAPB Taking Action to Implement the First Ever UN General Assembly Resolution Recognizing the Link Between Eye Health and Sustainable Development
OSAKA, Japan–(BUSINESS WIRE)–It was announced that Santen, in partnership with the IAPB, will take action to implement UN General Assembly Resolution A/75/L.108 on eye health.
Aurion Biotech Announces IOTA Cell Therapy Trial
SEATTLE & BOSTON & TOKYO–(BUSINESS WIRE)–Aurion Biotech announces IOTA cell therapy trial. Cells from two donors treated 50 Patients with corneal endothelial disease.
Allegro Ophthalmics Announces Positive Results of Vehicle-controlled Ex-U.S. Phase 2 Trial of ALG-1007 for the Treatment of Dry Eye Disease
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)– #ASCRS2021–Allegro Ophthalmics announces positive results of ex-U.S. Phase 2 trial of ALG-1007 for the treatment of dry eye disease; FDA acceptance of IND.
Modernizing Medicine® Showcases Single-Screen Innovations at the 2021 ASCRS Annual Meeting
BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine® today announced it has enhanced its electronic health records (EHR), EMA®, with functionality that can help to speed up documentation by removing steps in note-taking and allowing for quick editi…
Ocular Therapeutix™ To Present Clinical Data at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
FORT WORTH, Texas–(BUSINESS WIRE)–Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
FORT WORTH, Texas–(BUSINESS WIRE)–Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
Ocular Therapeutix™ Announces Second Quarter 2021 Preliminary Net Product Revenue of $11.7 Million
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today r…
Worldwide Ophthalmic Operating Room Microscope Industry to 2027 – Players Include Carl Zeiss, Danaher and Topcon Among Others – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Operating Room Microscope Market By Indication, By Product, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021 – 2027” report has been added to ResearchAndMarkets.com’s offering…
2021 Report on Retinal Degeneration Drugs in Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Degeneration (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Retinal Degeneration pipeline landscape. The report pro…
Global Graves Ophthalmopathy Market to 2030 – Insight, Epidemiology and Market Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Graves Ophthalmopathy – Market Insight, Epidemiology and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Graves Ophthalmopathy, hist…
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Society of Cataract and Refractive Surgery Annual Meeting
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
US Retinitis Pigmentosa Market and Competitive Landscape Report 2021: Epidemiology, Key Products Marketed, Market Valuations and Forecast, Drugs Sales and Market Shares 2017-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Retinitis Pigmentosa Market and Competitive Landscape – 2021” report has been added to ResearchAndMarkets.com’s offering. US Retinitis Pigmentosa Market and Competitive Landscape Highlights – 2021, provides comprehensiv…